Yes, I read or heard somewhere (maybe RP statement) that 90% of cancer deaths are due to metastasis. This year there are over 500,000 expected cancer deaths in the US alone. Even a small penetration on these advanced cancer patients will be huge for leronlimab. Add in newly diagnosed cancers and the fact these patients will likely be on leronlimab for the remainder of their lives and the number grows exponentially. Please inject soon!
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.